Literature DB >> 8434327

Psychiatric illness and chronic low-back pain. The mind and the spine--which goes first?

P B Polatin1, R K Kinney, R J Gatchel, E Lillo, T G Mayer.   

Abstract

Two hundred chronic low-back pain patients entering a functional restoration program were assessed for current and lifetime psychiatric syndromes using a structured psychiatric interview to make DSM-III-R diagnoses. Results showed that, even when the somewhat controversial category of somatoform pain disorder was excluded, 77% of patients met lifetime diagnostic criteria and 59% demonstrated current symptoms for at least one psychiatric diagnosis. The most common of these were major depression, substance abuse, and anxiety disorders. In addition, 51% met criteria for at least one personality disorder. All of the prevalence rates were significantly greater than the base rate for the general population. Finally, and most importantly, of these patients with a positive lifetime history for psychiatric syndromes, 54% of those with depression, 94% of those with substance abuse, and 95% of those with anxiety disorders had experienced these syndromes before the onset of their back pain. These are the first results to indicate that certain psychiatric syndromes appear to precede chronic low-back pain (substance abuse and anxiety disorders), whereas others (specifically, major depression) develop either before or after the onset of chronic low-back pain. Such findings substantially add to our understanding of causality and predisposition in the relationship between psychiatric disorders and chronic low-back pain. They also clearly reveal that clinicians should be aware of potentially high rates of emotional distress syndromes in chronic low-back pain and enlist mental health professionals to help maximize treatment outcomes.

Entities:  

Mesh:

Year:  1993        PMID: 8434327     DOI: 10.1097/00007632-199301000-00011

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  69 in total

1.  Prognostic factors and treatment-related changes associated with return to work in the multimodal treatment of chronic back pain.

Authors:  A A Vendrig
Journal:  J Behav Med       Date:  1999-06

2.  Psychosocial differences in high risk versus low risk acute low-back pain patients.

Authors:  C B Pulliam; R J Gatchel; M A Gardea
Journal:  J Occup Rehabil       Date:  2001-03

Review 3.  Personality and personality disorders in chronic pain.

Authors:  J N Weisberg
Journal:  Curr Rev Pain       Date:  2000

Review 4.  The relevance of health anxiety to chronic pain: research findings and recommendations for assessment and treatment.

Authors:  Heather D Hadjistavropoulos; Thomas Hadjistavropoulos
Journal:  Curr Pain Headache Rep       Date:  2003-04

Review 5.  The future of disc surgery and regeneration.

Authors:  Zorica Buser; Andrew S Chung; Aidin Abedi; Jeffrey C Wang
Journal:  Int Orthop       Date:  2018-11-30       Impact factor: 3.075

6.  The pain disability questionnaire: relationship to one-year functional and psychosocial rehabilitation outcomes.

Authors:  Robert J Gatchel; Tom G Mayer; Brian R Theodore
Journal:  J Occup Rehabil       Date:  2006-03

7.  Depressive symptoms and disability in acute and chronic back pain patients.

Authors:  M Kessler; R Kronstorfer; H C Traue
Journal:  Int J Behav Med       Date:  1996

Review 8.  [Risk factors for substance abuse and dependence in opioid therapy for chronic noncancer-related pain].

Authors:  J Jage; A Willweber-Strumpf; C Maier
Journal:  Schmerz       Date:  2005-10       Impact factor: 1.107

9.  Changes in psychopathology following functional restoration of chronic low back pain patients: A prospective study.

Authors:  E Owen-Salters; R J Gatchel; P B Polatin; T G Mayer
Journal:  J Occup Rehabil       Date:  1996-12

10.  Psychiatric Disorders Among Patients Seeking Treatment for Co-Occurring Chronic Pain and Opioid Use Disorder.

Authors:  Declan T Barry; Christopher J Cutter; Mark Beitel; Robert D Kerns; Christopher Liong; Richard S Schottenfeld
Journal:  J Clin Psychiatry       Date:  2016-10       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.